Badry Bursulaya
Title
Cited by
Cited by
Year
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
J Zhang, FJ Adrián, W Jahnke, SW Cowan-Jacob, AG Li, RE Iacob, T Sim, ...
Nature 463 (7280), 501-506, 2010
5612010
Overcoming EGFR (T790M) and EGFR (C797S) resistance with mutant-selective allosteric inhibitors
Y Jia, CH Yun, E Park, D Ercan, M Manuia, J Juarez, C Xu, K Rhee, ...
Nature 534 (7605), 129-132, 2016
4662016
Comparative study of several algorithms for flexible ligand docking
BD Bursulaya, M Totrov, R Abagyan, CL Brooks
Journal of computer-aided molecular design 17 (11), 755-763, 2003
4372003
Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5 …
TH Marsilje, W Pei, B Chen, W Lu, T Uno, Y Jin, T Jiang, S Kim, N Li, ...
Journal of medicinal chemistry 56 (14), 5675-5690, 2013
3552013
Targeting Plasmodium PI(4)K to eliminate malaria
CW McNamara, MCS Lee, CS Lim, SH Lim, J Roland, A Nagle, O Simon, ...
Nature 504 (7479), 248-253, 2013
3182013
Identification of transmembrane domain 5 as a critical molecular determinant of menthol sensitivity in mammalian TRPA1 channels
B Xiao, AE Dubin, B Bursulaya, V Viswanath, TJ Jegla, A Patapoutian
Journal of Neuroscience 28 (39), 9640-9651, 2008
2852008
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
S Khare, AS Nagle, A Biggart, YH Lai, F Liang, LC Davis, SW Barnes, ...
Nature 537 (7619), 229-233, 2016
2662016
Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I
T Jiang, KL Kuhen, K Wolff, H Yin, K Bieza, J Caldwell, B Bursulaya, ...
Bioorganic & medicinal chemistry letters 16 (8), 2105-2108, 2006
2262006
Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility
N Kato, T Sakata, G Breton, KG Le Roch, A Nagle, C Andersen, ...
Nature chemical biology 4 (6), 347-356, 2008
2202008
Golgicide A reveals essential roles for GBF1 in Golgi assembly and function
JB Saenz, WJ Sun, JW Chang, J Li, B Bursulaya, NS Gray, DB Haslam
Nature chemical biology 5 (3), 157-165, 2009
2082009
In vivo Incorporation of Unnatural Amino Acids to Probe Structure, Dynamics, and Ligand Binding in a Large Protein by Nuclear Magnetic Resonance Spectroscopy
SE Cellitti, DH Jones, L Lagpacan, X Hao, Q Zhang, H Hu, SM Brittain, ...
Journal of the American Chemical Society 130 (29), 9268-9281, 2008
2042008
Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2
T Jiang, KL Kuhen, K Wolff, H Yin, K Bieza, J Caldwell, B Bursulaya, ...
Bioorganic & medicinal chemistry letters 16 (8), 2109-2112, 2006
1912006
Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
Z Zhang, L Alfonta, F Tian, B Bursulaya, S Uryu, DS King, PG Schultz
Proceedings of the National Academy of Sciences 101 (24), 8882-8887, 2004
1892004
Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain
J Grandl, SE Kim, V Uzzell, B Bursulaya, M Petrus, M Bandell, ...
Nature neuroscience 13 (6), 708-714, 2010
1812010
Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction
TYH Wu, KW Wagner, B Bursulaya, PG Schultz, QL Deveraux
Chemistry & biology 10 (8), 759-767, 2003
1682003
Pore region of TRPV3 ion channel is specifically required for heat activation
J Grandl, H Hu, M Bandell, B Bursulaya, M Schmidt, M Petrus, ...
Nature neuroscience 11 (9), 1007-1013, 2008
1572008
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
E Malito, B Bursulaya, C Chen, PL Surdo, M Picchianti, E Balducci, ...
Proceedings of the National Academy of Sciences 109 (14), 5229-5234, 2012
1282012
Folding free energy surface of a three-stranded β-sheet protein
BD Bursulaya, CL Brooks
Journal of the American Chemical Society 121 (43), 9947-9951, 1999
1141999
Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH)
DC Tully, PV Rucker, D Chianelli, J Williams, A Vidal, PB Alper, D Mutnick, ...
Journal of medicinal chemistry 60 (24), 9960-9973, 2017
1052017
Comparative study of the folding free energy landscape of a three-stranded β-sheet protein with explicit and implicit solvent models
BD Bursulaya, CL Brooks
The Journal of Physical Chemistry B 104 (51), 12378-12383, 2000
1032000
The system can't perform the operation now. Try again later.
Articles 1–20